Literature DB >> 25753481

Initial experience of use of tolvaptan in critically ill patients with fluid overload.

J Ruiz-Ramos1, M Gordon, M A Cortes, M J Broch, P Ramirez.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: Positive volume balance is related with high mortality in critically ill patients. We describe our experience in the use of tolvaptan in patients with fluid overload. CASE
SUMMARY: Six patients in the recovery phase from septic shock were included. All patients achieved an increase in diuresis after the first day, with a median fluid balance variation of -2362 (-485 to -3447) mL. At the end of treatment, median fluid balance variation was -9080 (-26,784 to -4395) mL. WHAT IS NEW AND
CONCLUSION: Tolvaptan could be an option in critically ill patients with fluid overload and resistant or not treatable with conventional diuretics.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  clinical pharmacy; drug utilisation; furosemide

Mesh:

Substances:

Year:  2015        PMID: 25753481     DOI: 10.1111/jcpt.12255

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  1 in total

1.  Vasopressin antagonist efficacy and safety in volume-overloaded critically ill patients: a new therapeutic alternative.

Authors:  Jesús Ruiz-Ramos; Paula Ramírez; María Jesús Broch; Mónica Gordon; Esther Villarreal; Armando Pinos; Manuel Sosa; Álvaro Castellanos-Ortega
Journal:  Eur J Hosp Pharm       Date:  2018-11-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.